Source-backed public directory
Publicly reported investors in Latus Bio
Latus Bio is developing curative AAV gene therapy products for CNS disorders
This evidence-based directory lists investors publicly reported in the sources below. It may not be complete.
Browse more publicly reported investors
- Biotech investors
- Health investors
- Gene Therapy investors
- Therapeutics investors
- All publicly reported investors
Other Biotech companies with publicly reported investors